Colonial Trust Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$298 Hold
22
﹤0.01% 778
2026
Q1
$132 Hold
22
﹤0.01% 704
2025
Q4
$158 Hold
22
﹤0.01% 679
2025
Q3
$235 Sell
22
-318
-94% -$3.12K ﹤0.01% 664
2025
Q2
$3.29K Sell
340
-829
-71% -$8.55K ﹤0.01% 618
2025
Q1
$17.4K Buy
1,169
+114
+11% +$1.75K ﹤0.01% 444
2024
Q4
$15.7K Sell
1,055
-309
-23% -$5.04K ﹤0.01% 434
2024
Q3
$26.1K Hold
1,364
﹤0.01% 403
2024
Q2
$28.2K Buy
1,364
+1
+0.1% +$20 ﹤0.01% 379
2024
Q1
$25.6K Hold
1,363
﹤0.01% 429
2023
Q4
$19.7K Sell
1,363
-65
-5% -$884 ﹤0.01% 417
2023
Q3
$24.8K Hold
1,428
﹤0.01% 401
2023
Q2
$29.7K Sell
1,428
-19
-1% -$413 ﹤0.01% 390
2023
Q1
$34K Buy
1,447
+86
+6% +$2.31K ﹤0.01% 377
2022
Q4
$38K Buy
+1,361
New +$34.8K ﹤0.01% 359

Other funds holding OGN

Colonial Trust Advisors's OGN Position: Q2 2026 in Review

Colonial Trust Advisors held its Organon & Co (OGN) position steady in Q2 2026 at 22 shares worth $298. The position accounts for ﹤0.01% of the portfolio, ranked #778.

Colonial Trust Advisors first reported a position in OGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $38K in Q4 2022. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Colonial Trust Advisors held 22 shares of Organon & Co worth $298 as of Q2 2026.
  • Colonial Trust Advisors left its Organon & Co share count unchanged in Q2 2026.
  • Organon & Co made up ﹤0.01% of Colonial Trust Advisors's portfolio in Q2 2026, its #778 holding.
  • Colonial Trust Advisors first reported a position in Organon & Co in Q4 2022 and has held it in 15 quarters since.
  • Colonial Trust Advisors's Organon & Co position peaked at $38K in Q4 2022.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Colonial Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.